Clinical Trials Browser

Phase NA × Pancreatic Adenocarcinoma Resectable × Clear all

NCT06966440 2025-07-15

ADAPT-MRD

Phase NA Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma Resectable

NCT03337997 2021-05-06

A Pilot Study of IRE for Resectable Pancreatic Cancer

Phase NA Withdrawn

Gastrointestinal

Pancreatic Adenocarcinoma Resectable